insulin-degludec and dapagliflozin

insulin-degludec has been researched along with dapagliflozin* in 1 studies

Reviews

1 review(s) available for insulin-degludec and dapagliflozin

Article	Year
[New drugs in type 2 diabetes mellitus therapy]. Vnitrni lekarstvi, 2013, Volume: 59, Issue:8 The objective in developing a new type 2 diabetes therapy is to achieve greater safety and better efficacy. Newly registered drugs include lixisenatide, QW exenatide, dapagliflozin and insulin degludec. Once weekly gliptins and other substances are under development. Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Schedule; Exenatide; Glucosides; Humans; Hypoglycemic Agents; Insulin, Long-Acting; Peptides; Venoms	2013

Article

Year

[New drugs in type 2 diabetes mellitus therapy].

Vnitrni lekarstvi, 2013, Volume: 59, Issue:8

The objective in developing a new type 2 diabetes therapy is to achieve greater safety and better efficacy. Newly registered drugs include lixisenatide, QW exenatide, dapagliflozin and insulin degludec. Once weekly gliptins and other substances are under development.

Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Schedule; Exenatide; Glucosides; Humans; Hypoglycemic Agents; Insulin, Long-Acting; Peptides; Venoms

2013